Cost-Effectiveness of Amphotericin B
Cost-Effectiveness of Different Formulation of Amphotericin B in Private and Public Hospitals in Southern Brazil
Sponsor: Hospital Universitario Evangelico de Curitiba
Listed as NCT02527928, this observational or N/A phase trial focuses on Invasive Fungal Infections and remains ongoing. Sponsored by Hospital Universitario Evangelico de Curitiba, it has been updated 7 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
▶ Show 2 earlier versions
-
Sep 2017 — Apr 2018 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — Sep 2017 [monthly]
Not Yet Recruiting NA
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Universitario Evangelico de Curitiba
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.